Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charmaine Gibson

Obstetrics Richardson, TX Medical Doctor

NPI 1538390232 CMS profile 23931

2821 E President George Bush Hwy Ste 400, Richardson, TX 75082

Open in the dashboard

General payments

$2,224

92 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$511,751 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Charmaine Gibson of Richardson, TX is reported in the CMS Open Payments database as having received $2,224 across 92 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $511,751 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 75th percentile of Obstetrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $813 24
2024 General $523 18
2023 General $357 19
2022 General $344 18
2021 General $8 1
2020 General $25 2
2019 General $154 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charmaine Gibson
  • Obstetrics median
  • Middle half of Obstetrics
  • National median

In program year 2025, general payments to Charmaine Gibson were reported at $813. Among 649 Obstetrics profiles paid that year, the median was $181 and the middle half received between $61 and $424.

Show as a table
Year Charmaine Gibson Obstetrics median Middle half National median
2019 $154 $177 $60–$381 $163
2020 $25 $92 $35–$201 $114
2021 $8 $125 $40–$351 $132
2022 $344 $186 $65–$448 $149
2023 $357 $183 $61–$451 $160
2024 $523 $176 $62–$406 $164
2025 $813 $181 $61–$424 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Baxter Healthcare $439 9 payments
  2. Astellas Pharma US Inc $328 5 payments
  3. Organon LLC $225 10 payments
  4. Sumitomo Pharma America, Inc. $225 12 payments
  5. AbbVie, Inc. $144 7 payments
  6. Pfizer Inc. $111 6 payments
  7. Sage Therapeutics, Inc. $87 5 payments
  8. Dexcom, Inc. $75 3 payments
  9. TherapeuticsMD, Inc. $66 4 payments
  10. Exeltis, USA Inc. $64 4 payments
  11. Other $459 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,921 88 payments
  2. Education $304 4 payments
Products named General payments · program years 2019–2025
  1. TISSEEL $394 7 payments
  2. NEXPLANON $217 9 payments
  3. MYFEMBREE Hormone Therapy $199 10 payments
  4. PREMARIN $133 7 payments
  5. MYFEMBREE Genitourinary (Sexual Health);Womens Health $111 6 payments
  6. LO LOESTRIN FE $85 5 payments
  7. Dexcom G6 Transmitter $75 3 payments
  8. MYFEMBREE Womens Health $73 4 payments
  9. NURTEC ODT $69 4 payments
  10. ZURZUVAE $54 3 payments
  11. Other $1,114 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record